•
Jun 30, 2023
Avantor Q2 2023 Earnings Report
Avantor's financial performance reflected a challenging biopharma market, with strategic actions taken to offset headwinds and invest in long-term growth.
Key Takeaways
Avantor reported a decrease in net sales by 8.7% to $1.74 billion, with a core organic decline of 6.5%. Net income was ($7.3) million, while adjusted EBITDA reached $343.0 million. The company's diluted GAAP EPS was ($0.01), and adjusted EPS was $0.28. Operating cash flow was $168.2 million, and free cash flow was $138.1 million.
Net sales decreased by 8.7% to $1.74 billion, with a core organic decline of 6.5%.
Adjusted EBITDA was $343.0 million with a margin of 19.7%.
Diluted GAAP EPS was ($0.01), and adjusted EPS was $0.28.
Operating cash flow was $168.2 million, and free cash flow was $138.1 million.
Avantor
Avantor
Avantor Revenue by Geographic Location
Forward Guidance
No forward guidance was provided in the press release.
Revenue & Expenses
Visualization of income flow from segment revenue to net income